Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
ZT ZTS Zoetis Inc. FY ended Feb 06, 2026 | $77.34 | $31.96B | $41.06B | $9.47B | $4.07B | $2.67B | 12.85x | 3.38x | 9.38x |
EL ELAN Elanco Animal Health Inc FY ended Feb 19, 2026 | $24.11 | $12.05B | $15.41B | $4.72B | $691.00M | -$232.00M | -51.30x | 2.55x | 17.18x |
PA PAHC PHIBRO ANIMAL HEALTH CORP FY ended Jun 30, 2026 | $35.34 | $2.44B | $3.26B | $1.52B | $207.54M | $99.72M | 14.54x | 1.60x | 12.85x |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 13.27x | 3/3 | -$969.76M | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 2.51x | 3/3 | $80.45M | $0.08 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | -7.97x | 3/3 | $652.34M | $0.67 | Peer averages are not economically meaningful for this method. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
ZT ZTS Zoetis Inc. FY ended Feb 06, 2026 | $77.34 | $31.96B | $41.06B | $9.47B | $4.07B | $2.67B | 12.85x | 3.38x | 9.38x |
EL ELAN Elanco Animal Health Inc FY ended Feb 19, 2026 | $24.11 | $12.05B | $15.41B | $4.72B | $691.00M | -$232.00M | -51.30x | 2.55x | 17.18x |
PA PAHC PHIBRO ANIMAL HEALTH CORP FY ended Jun 30, 2026 | $35.34 | $2.44B | $3.26B | $1.52B | $207.54M | $99.72M | 14.54x | 1.60x | 12.85x |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 13.27x | 3/3 | -$969.76M | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 2.51x | 3/3 | $80.45M | $0.08 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | -7.97x | 3/3 | $652.34M | $0.67 | Peer averages are not economically meaningful for this method. |
